loadpatents
name:-0.024266004562378
name:-0.017969846725464
name:-0.0023181438446045
Kuo; Sheng-Chu Patent Filings

Kuo; Sheng-Chu

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kuo; Sheng-Chu.The latest application filed is for "novel derivatives of curcuminoids and use thereof as an anticancer agent".

Company Profile
2.38.41
  • Kuo; Sheng-Chu - Taichung TW
  • Kuo; Sheng-Chu - Tainan TW
  • KUO; Sheng-Chu - Tainan City TW
  • Kuo; Sheng-Chu - Taichung City TW
  • Kuo, Sheng-Chu - Tai Chung TW
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Derivatives of curcuminoids and use thereof as an anticancer agent
Grant 10,787,413 - Kuo , et al. September 29, 2
2020-09-29
Novel Derivatives Of Curcuminoids And Use Thereof As An Anticancer Agent
App 20190161430 - KUO; SHENG-CHU ;   et al.
2019-05-30
Bicyclic compound and pharmaceutical composition thereof for treating stroke and use thereof
Grant 10,035,791 - Lee , et al. July 31, 2
2018-07-31
Bicyclic Compound And Pharmaceutical Composition Thereof For Treating Stroke And Use Thereof
App 20170298049 - LEE; Kuo-Hsiung ;   et al.
2017-10-19
20(S)-sulfonylamidine derivatives of camptothecin and the use thereof as a potent antitumor agent
Grant 9,718,835 - Lee , et al. August 1, 2
2017-08-01
Benzimidazole Compounds And Their Application In Cardiovascular Diseases
App 20170152245 - Huang; Tur-Fu ;   et al.
2017-06-01
Novel 20(s)-sulfonylamidine Derivatives Of Camptothecin And The Use Thereof As A Potent Antitumor Agent
App 20160229862 - LEE; Kuo-Hsiung ;   et al.
2016-08-11
Stilbenoid compound as inhibitor for squamous carcinoma and hepatoma and uses thereof
Grant 9,266,813 - Kuo , et al. February 23, 2
2016-02-23
2-aryl-4-quinazolinones and their pharmaceutical compositions
Grant 9,045,437 - Hour , et al. June 2, 2
2015-06-02
2-phenyl-4-quinolones as anticancer agents
Grant 9,029,394 - Kuo , et al. May 12, 2
2015-05-12
Hydrophilic derivatives of 2-selenophene-4-quinolones as anticancer agents
Grant 9,023,867 - Kuo , et al. May 5, 2
2015-05-05
2-selenophene-4-quinolones as anticancer agents
Grant 9,023,866 - Kuo , et al. May 5, 2
2015-05-05
2-aryl-4-quinazolinones and their pharmaceutical compositions
Grant 9,006,239 - Hour , et al. April 14, 2
2015-04-14
Method For Inhibiting Ezh2 Expression In Breast Cancer Cells
App 20140357688 - Kuo; Sheng-Chu ;   et al.
2014-12-04
Stilbenoid Compound As Inhibitor For Squamous Carcinoma And Hepatoma And Uses Thereof
App 20140303241 - Kuo; Sheng-Chu ;   et al.
2014-10-09
2-aryl-4-quinazolinones and their pharmaceutical compositions
Grant 8,710,064 - Hour , et al. April 29, 2
2014-04-29
2-aryl-4-quinazolinones And Their Pharmaceutical Compositions
App 20140018363 - Hour; Mann-Jen ;   et al.
2014-01-16
2-aryl-4-quinazolinones And Their Pharmaceutical Compositions
App 20130310376 - Hour; Mann-Jen ;   et al.
2013-11-21
2-selenophene-4-quinolones As Anticancer Agents
App 20130253006 - KUO; Sheng-Chu ;   et al.
2013-09-26
2-phenyl-4-quinolones As Anticancer Agents
App 20130252999 - KUO; Sheng-Chu ;   et al.
2013-09-26
Novel Hydrophilic Derivatives Of 2-selenophene-4-quinolones As Anticancer Agents
App 20130244983 - KUO; Sheng-Chu ;   et al.
2013-09-19
Synthesis and anticancer activity of aryl and heteroaryl-quinolin derivatives
Grant 8,524,740 - Kuo , et al. September 3, 2
2013-09-03
Benzimidazole compounds and their use as anticancer agents
Grant 8,501,957 - Chang , et al. August 6, 2
2013-08-06
Hydrophilic derivatives of 2-aryl-4-quinolones as anticancer agents
Grant 8,440,692 - Kuo , et al. May 14, 2
2013-05-14
2-Aryl-4-Quinazolinones And Their Pharmaceutical Compositions
App 20130102602 - Hour; Mann-Jen ;   et al.
2013-04-25
Synthesis And Anticancer Activity Of Aryl And Heteroaryl-quinolin Derivatives
App 20120015908 - Kuo; Sheng-Chu ;   et al.
2012-01-19
Selenolopyrazole derivatives and use thereof as anticancer agents
Grant 8,053,459 - Kuo , et al. November 8, 2
2011-11-08
Fused pyrazolyl compounds having an aminoalkylcarbonyl group
Grant 7,767,707 - Kuo , et al. August 3, 2
2010-08-03
Benzimidazole Compounds And Their Use As Anticancer Agents
App 20100179147 - Chang; Chih-Shiang ;   et al.
2010-07-15
Preferential inhibition of release of pro-inflammatory cytokines
Grant 7,754,751 - Teng , et al. July 13, 2
2010-07-13
Novel Hydrophilic Derivatives Of 2-aryl-4-quinolones As Anticancer Agents
App 20100168064 - Kuo; Sheng-Chu ;   et al.
2010-07-01
Novel fused pyrazolyl compounds having an aminoalkylcarbonyl group
App 20090131681 - Kuo; Sheng-Chu ;   et al.
2009-05-21
Synthesis of N.sup.2-(substituted arylmethyl)-3-(substituted phenyl)indazoles as novel anti-angiogenic agents
Grant 7,514,465 - Kuo , et al. April 7, 2
2009-04-07
Fused pyrazolyl compound
Grant 7,378,532 - Kuo , et al. May 27, 2
2008-05-27
Treatment of disorder related to low cyclic GMP levels
Grant 7,345,079 - Teng , et al. March 18, 2
2008-03-18
Hydrophilic analogs of 4,8-dihydrobenzodithiophene-4,8-diones as anticancer agents
Grant 7,332,615 - Huang , et al. February 19, 2
2008-02-19
Cancer chemotherapy
App 20070149554 - Kuo; Sheng-Chu ;   et al.
2007-06-28
Angiogenesis inhibitors
App 20070142449 - Teng; Che-Ming ;   et al.
2007-06-21
Synthesis of indole analogs of 1-benzyl-3-(5'-hydroxymethyl-2'-furyl) indazole (YC-1) as anti-platelet agents
Grant 7,176,230 - Kuo , et al. February 13, 2
2007-02-13
Angiogenesis inhibitors
Grant 7,166,293 - Teng , et al. January 23, 2
2007-01-23
Method of increasing bone density or treating osteoporosis
Grant 7,160,916 - Fu , et al. January 9, 2
2007-01-09
Enhancement of learning and memory and treatment of amnesia
Grant 7,049,334 - Fu , et al. May 23, 2
2006-05-23
Synthesis of indole analogs of 1-benzyl-3-(5'-hydroxymethy 1-2' -furyl) indazole (YC-1) as anti-platelet agents
App 20060106041 - Kuo; Sheng-Chu ;   et al.
2006-05-18
Synthesis of N2 - (substituted arylmethyl) -3- (substituted phenyl) indazoles as novel anti-angiogenic agents
App 20060106032 - Kuo; Sheng-Chu ;   et al.
2006-05-18
Novel hydrophilic analogs of 4,8-dihydrobenzodithiophene-4,8-diones as anticancer agents
App 20060069041 - Huang; Pi-Tsan ;   et al.
2006-03-30
Novel fused pyrazolyl compound
App 20050215612 - Kuo, Sheng-Chu ;   et al.
2005-09-29
Preferential inhibition of release of pro-inflammatory cytokines
App 20050215613 - Teng, Che-Ming ;   et al.
2005-09-29
Cancer treatment
App 20050209252 - Teng, Che-Ming ;   et al.
2005-09-22
Anti-fungal pharmaceutical compositions comprising an active ingredient prepared from Zingiber officinale
Grant 6,946,153 - Wu , et al. September 20, 2
2005-09-20
Methods of treating sepsis
Grant 6,943,186 - Teng , et al. September 13, 2
2005-09-13
Methods of treating sepsis
App 20050187257 - Teng, Che-Ming ;   et al.
2005-08-25
Flavone acetic acid analogs and methods of use thereof
App 20050171138 - Lee, Kuo-Hsiung ;   et al.
2005-08-04
Flavone acetic acid analogs and methods of use thereof
Grant 6,916,831 - Lee , et al. July 12, 2
2005-07-12
Enhancement of bone growth and inhibition of bone resorption
App 20050131048 - Fu, Wen-Mei ;   et al.
2005-06-16
Anti-angiogenesis methods
App 20050119278 - Teng, Che-Ming ;   et al.
2005-06-02
Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents
Grant 6,897,316 - Kuo , et al. May 24, 2
2005-05-24
Angiogenesis inhibitors
App 20050107406 - Teng, Che-Ming ;   et al.
2005-05-19
Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents
App 20050032832 - Kuo, Sheng-Chu ;   et al.
2005-02-10
Flavone acetic acid analogs and methods of use thereof
App 20040167151 - Lee, Kuo-Hsiung ;   et al.
2004-08-26
Treatment of nuerodegenerative diseases
App 20040077702 - Fu, Wen-Mei ;   et al.
2004-04-22
Treatment of disorder related to low cyclic GMP levels
App 20030220385 - Teng, Che-Ming ;   et al.
2003-11-27
Anti-fungal pharmaceutical compositions comprising an active ingredient prepared from Zingiber officinal
App 20030203059 - Wu, Tian-Shung ;   et al.
2003-10-30
Angiogenesis inhibitors
App 20030186996 - Teng, Che-Ming ;   et al.
2003-10-02
Methods of treating sepsis
App 20030181502 - Teng, Che-Ming ;   et al.
2003-09-25
Enhancement of learning and memory and treatment of amnesia
App 20030105149 - Fu, Wen-Mei ;   et al.
2003-06-05
Fused pyrazolyl compounds
Grant 6,518,294 - Teng , et al. February 11, 2
2003-02-11
Fused pyrazolyl compounds
App 20030004355 - Teng, Che-Ming ;   et al.
2003-01-02
2-phenyl-4-quinazolinone compounds, 2-phenyl-4-alkoxy-quinazoline compounds and their pharmaceutical compositions
Grant 6,479,499 - Kuo , et al. November 12, 2
2002-11-12
Anti-fungal pharmaceutical compositions comprising an active ingredient prepared from Zingiber officinal
App 20020044979 - Wu, Tian-Shung ;   et al.
2002-04-18
Method of treating disorders related to protease-activated receptors-induced cell activation
App 20020004518 - Teng, Che-Ming ;   et al.
2002-01-10
Method of preparing an extract potent in anti-inflammation and anti-platelet aggregation from Zingiber officinale and pharmaceutical compositions containing said extract
Grant 6,274,177 - Wu , et al. August 14, 2
2001-08-14
Naphthoquinone antitumor compound and method
Grant 5,789,431 - Lee , et al. August 4, 1
1998-08-04
Helper inducers for differentiation therapy and chemoprevention of cancer
Grant 5,783,605 - Kuo , et al. July 21, 1
1998-07-21
1-(substituted benzyl)-3-(substituted aryl)-condensed pyrazole derivatives and processes of making the same
Grant 5,574,168 - Kuo , et al. November 12, 1
1996-11-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed